5 Tirzepatide Telehealth Services I’d Actually Pay For in 2026

Most people shopping for tirzepatide online assume the biggest brand name equals the best deal. That’s usually wrong. Pricing in this category is genuinely chaotic, pharmacy transparency is rare, and the gap between what companies advertise and what you actually pay monthly can be hundreds of dollars.

I spent time comparing the real numbers, the pharmacy sourcing, and the monitoring models across a crowded field. Here’s what I found worth recommending.

What I Looked At

Before getting into the picks, a quick word on criteria. I focused on:

• Cash price for tirzepatide specifically (not the teaser semaglutide rate)
• Pharmacy identity and standards (named 503A facility versus vague “compounding partner”)
• Speed of physician review and shipping
• Monitoring depth (some services are basically a prescription vending machine; others give you an actual clinician)
• State availability and shipping cost

One important context: the FDA sent warning letters to 30-plus telehealth and compounding firms in early 2026, and a March 2026 settlement between Novo Nordisk and several pharmacies pushed many platforms toward branded medications. Any compounded tirzepatide you see here is not FDA-approved. That matters, and I’ll say it plainly below.

The 5 Picks

1. HealthRX

The thing that pulled HealthRX to the top of this list is the combination of low entry price and named, auditable pharmacy sourcing, which almost no competitor at this price point bothers to provide.

Compounded tirzepatide starts at $149 per month with free overnight shipping to all 50 states. That’s a meaningful gap below most telehealth services offering compounded tirzepatide in the $199 to $249 range. The medication ships from Manifest Pharmacy in Greer, South Carolina, a 503A compounding pharmacy operating under USP-797 standards with lot-level tracking from production through delivery. LegitScript certification (certificate 50087439) is publicly verifiable. After you complete an online health assessment, a board-certified U.S. physician reviews it within roughly 24 hours. No hidden enrollment fees. No ongoing membership charge stacked on top of the medication cost.

The clinical data HealthRX references comes from actual trials: the SURMOUNT-1 study recorded approximately 21% body weight reduction at 72 weeks with tirzepatide; semaglutide showed roughly 15% at 68 weeks in STEP-1. These are trial results, not HealthRX’s own outcomes, and the distinction matters.

Compounded medications are not FDA-approved, and this is a cash-pay model with lighter monitoring than, say, a clinic with a dedicated obesity medicine team. But for a healthy adult who simply wants legitimate compounded tirzepatide at a fair price, shipped fast from a pharmacy they can actually look up, HealthRX does that cleanly.

2. FormBlends

FormBlends earns a spot here for a specific type of buyer: someone who wants published analytical testing on their compounded GLP-1, or someone who is also interested in peptides beyond weight loss from a single clinician-overseen provider.

Semaglutide runs around $299 per vial and tirzepatide around $349, which is higher than HealthRX’s entry pricing. That premium buys something real, though. FormBlends publishes per-product purity data including HPLC purity percentages, mass spectrometry identity confirmation, and endotoxin and sterility results. That level of documentation is uncommon in this space. The compounding is done through an FDA-registered 503A pharmacy, and physician oversight is part of the model. Shipping covers 47 states, not 50, which is a minor limitation worth knowing.

The wider peptide catalog, covering recovery, cognitive, and longevity compounds under the same clinical framework, is genuinely useful if you’re already working with a provider and don’t want to open separate accounts elsewhere. HealthRX wins on price and national reach for tirzepatide specifically. FormBlends wins if purity documentation or catalog breadth matters more to you than cost.

3. Mochi Health

Mochi stands out in this category because it actually employs board-certified obesity medicine clinicians, not just general practitioners reviewing forms. Compounded tirzepatide runs around $199 per month for cash-pay patients. The monitoring is more hands-on than most telehealth-only options, which makes it a reasonable middle ground between a bare-bones prescription service and a full concierge program.

4. Hims & Hers

After the March 2026 Novo settlement, Hims & Hers moved away from compounded GLP-1s and now offers branded medications. Injectable Wegovy is listed at around $299 per month and Zepbound at roughly $399, though with insurance plus a savings card, some patients bring that down to near zero. If your insurance covers GLP-1s and you want a familiar, large-scale platform handling prior authorization, this is a practical option.

5. PlushCare

PlushCare’s membership is about $19.99 per month, which is among the lowest platform fees in the category. It connects to branded medications through insurance, offers same-day visit slots, and handles prior authorization support. The medication cost depends entirely on your plan. This makes PlushCare less useful for cash-pay patients and very useful for anyone with decent coverage who wants fast appointment access.

How to Choose

If you’re paying cash and want the lowest verifiable price on compounded tirzepatide from a named, auditable pharmacy, start with HealthRX. If you want purity testing documentation or a broader peptide catalog, FormBlends is worth the higher price. If clinician depth matters and you’re fine spending a bit more, Mochi is the standout. If you have insurance, Hims and Hers or PlushCare make more financial sense than any cash-pay compounded option.

One honest caution: compounded medications are not the same as FDA-approved branded drugs, and no telehealth platform can guarantee equivalent results. Get labs done, tell your primary care physician what you’re taking, and treat any “21% weight loss” figure as a population average from a controlled trial, not a personal promise.

Common Questions

Does HealthRX’s $149 price stay the same as you dose up?

It may not. Many compounded tirzepatide services price by dose, meaning higher maintenance doses cost more per month. Ask HealthRX directly what the per-vial or per-dose cost looks like at 10 mg and 15 mg before assuming the $149 entry rate holds through your full titration schedule.

What exactly does FormBlends’ purity documentation show, and why does it matter?

FormBlends publishes HPLC purity percentages, mass spectrometry identity confirmation, and sterility and endotoxin results per product. That matters because compounded peptides have no FDA pre-market review, so third-party analytical testing is the main way a buyer can verify that what’s in the vial matches the label claim.

If Hims & Hers no longer offers compounded tirzepatide, what changed after the March 2026 settlement?

The Novo Nordisk settlement pushed several large platforms, including Hims & Hers, away from compounded GLP-1s toward branded drugs. Hims & Hers now lists Wegovy and Zepbound at retail prices, with insurance and savings cards potentially reducing patient cost significantly, rather than offering lower-cost compounded alternatives.

Is Mochi Health’s obesity medicine model meaningfully different from a standard telehealth intake form?

Yes, in a specific way. Mochi employs board-certified obesity medicine specialists rather than routing patients through general practitioners who review asynchronous forms. That means follow-up visits and dose adjustments involve clinicians trained specifically in metabolic disease, which is a real distinction if you have complicating factors like thyroid history or prior medication failures.

Which of these services makes the most sense if you live in one of the three states FormBlends does not ship to?

HealthRX ships to all 50 states and prices compounded tirzepatide lower than FormBlends anyway. If you’re in a state outside FormBlends’ 47-state reach and want compounded tirzepatide, HealthRX is the direct alternative. If you have insurance, PlushCare or Hims & Hers are not limited by compounding pharmacy shipping restrictions at all.

Sources

• FDA warning letters to compounding/telehealth firms, 2026 (FDA.gov enforcement actions)
• SURMOUNT-1 phase 3 data published by Jastreboff and colleagues in the *New England Journal of Medicine*, 2022
• STEP-1 trial results, Wilding et al., *New England Journal of Medicine*, 2021
• LegitScript certification database (legitscript.com)
• Novo Nordisk compounding pharmacy settlement reporting, March 2026, *Reuters* and *STAT News*
• Lilly orforglipron / LillyDirect pricing announcement, April 2026, *Fierce Pharma*